Why? Maybe because human trials are literally right around the corner and these revolutionary medical interventions will be a smashing success. I predict the human trials will be very positive and the path to revenues will be fairly short in timespan. Fast forward 5-ish years and there are people justifying how this could exceed $50/share. See comments in the "superman" thread. Today's price is an awesome entry point for investors and is even below the institutional investor pricing from last March. Cash is my limiting factor right now, otherwise I'd be loading up now instead of the smaller lots I've been buying. Very much a no-brainer. Watch out when the hydrogels are up next. Great promise!